How common is familial cancer?

被引:64
作者
Hemminki, K. [1 ,2 ]
Sundquist, J. [2 ]
Bermejo, J. L. [1 ]
机构
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Ctr Famil & Community Med, Huddinge, Sweden
关键词
clinical genetic counselling; familial risk; referral of familial cancer; family history; cancer prevalence; familial proportion;
D O I
10.1093/annonc/mdm414
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Family history of a disease may point to its heritable or environmental etiology. It can be described by the proportion of the familial disease, i.e. same disease in two or more family members. A family history always needs to be specified as to the number of generations covered and their ages. Patients and methods: Proportions of site-specific familial cancers (familial proportions) were calculated using the Swedish Family-Cancer Database, the largest dataset of its kind in the world, with cancers from the Swedish Cancer Registry. Familial proportions refer to the offspring population up to age 72 years when their parents or siblings were diagnosed with a concordant (same) cancer. Results: A total of 34 cancer sites and 205 638 cases were covered. Prostate cancer showed the highest familial proportion of 20.15%, followed by breast (13.58%) and colorectal (12.80%) cancers. Salivary gland cancers showed the lowest familial proportion of 0.15%, but bone, laryngeal, anal, connective tissue and other genital cancers also remained < 1%. The familial proportion depended on the prevalence of the particular cancer and on its familial risk. Conclusions: The derived familial proportions can justifiably be used in statements 'X% of the patients had a family history of the cancer'.
引用
收藏
页码:163 / 167
页数:5
相关论文
共 31 条
[21]   The influence of mammographic screening on national trends in breast cancer incidence [J].
Moller, B ;
Weedon-Fekjær, H ;
Hakulinen, T ;
Tryggvadóttir, L ;
Storm, HH ;
Talbäck, M ;
Haldorsen, T .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2005, 14 (02) :117-128
[22]   Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history [J].
Murff, HJ ;
Spigel, DR ;
Syngal, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (12) :1480-1489
[23]   Highly penetrant hereditary cancer syndromes [J].
Nagy, R ;
Sweet, K ;
Eng, C .
ONCOGENE, 2004, 23 (38) :6445-6470
[24]  
*NAT BOARD HLTH WE, 2004, CANC INC SWED 2002
[25]   Implementation of service screening with mammography in Sweden:: from pilot study to nationwide programme [J].
Olsson, S ;
Andersson, I ;
Karlberg, I ;
Bjurstam, N ;
Frodis, E ;
Håkansson, S .
JOURNAL OF MEDICAL SCREENING, 2000, 7 (01) :14-18
[26]  
Peto J, 2001, EUR J CANCER, V37, pS88
[27]   Polygenic susceptibility to breast cancer and implications for prevention [J].
Pharoah, PDP ;
Antoniou, A ;
Bobrow, M ;
Zimmern, RL ;
Easton, DF ;
Ponder, BAJ .
NATURE GENETICS, 2002, 31 (01) :33-36
[28]  
Silva IsabelDos Santos., 1999, Cancer Epidemiology: Principles and Methods
[29]   Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients [J].
Syrjäkoski, K ;
Vahteristo, P ;
Eerola, H ;
Tamminen, A ;
Kivinummi, K ;
Sarantaus, L ;
Holli, K ;
Blomqvist, C ;
Kallioniemi, OP ;
Kainu, T ;
Nevanlinna, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) :1529-1531
[30]  
Thorlacius S, 1997, AM J HUM GENET, V60, P1079